Ørnbjerg, L. M. Et Al. 2023. One-Third of European Patients with Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment.. The Journal of rheumatology , vol.50 , 1009-1019.

Ørnbjerg, L. M., Rugbjerg, K., Georgiadis, S., Rasmussen, S. H., Lindström, U., Pavelka, K., ... Yilmaz, N.(2023). One-Third of European Patients with Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment.. The Journal of rheumatology , vol.50, 1009-1019.

Ørnbjerg, Lykke Et Al. "One-Third of European Patients with Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment.," The Journal of rheumatology , vol.50, 1009-1019, 2023

Ørnbjerg, Lykke M. Et Al. "One-Third of European Patients with Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment.." The Journal of rheumatology , vol.50, pp.1009-1019, 2023

Ørnbjerg, L. M. Et Al. (2023) . "One-Third of European Patients with Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment.." The Journal of rheumatology , vol.50, pp.1009-1019.

@article{article, author={Lykke Midtbøll Ørnbjerg Et Al. }, title={One-Third of European Patients with Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment.}, journal={The Journal of rheumatology}, year=2023, pages={1009-1019} }